| pubmed-article:7746341 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7746341 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:7746341 | lifeskim:mentions | umls-concept:C0040833 | lld:lifeskim |
| pubmed-article:7746341 | lifeskim:mentions | umls-concept:C0599851 | lld:lifeskim |
| pubmed-article:7746341 | lifeskim:mentions | umls-concept:C1521798 | lld:lifeskim |
| pubmed-article:7746341 | lifeskim:mentions | umls-concept:C0521116 | lld:lifeskim |
| pubmed-article:7746341 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7746341 | pubmed:dateCreated | 1995-6-13 | lld:pubmed |
| pubmed-article:7746341 | pubmed:abstractText | Basic laboratory studies in neural transplantation have promulgated some principles for clinical transplantation some of which are challenged by clinical experience. Chief amongst them are the restricted transplantation 'window' and the use of immunosuppression. Neural transplantation in man has largely been directed to Parkinson's Disease although other neurodegenerative diseases may prove suitable candidates. | lld:pubmed |
| pubmed-article:7746341 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7746341 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7746341 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7746341 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7746341 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7746341 | pubmed:issn | 0161-6412 | lld:pubmed |
| pubmed-article:7746341 | pubmed:author | pubmed-author:HitchcockEE | lld:pubmed |
| pubmed-article:7746341 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7746341 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:7746341 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7746341 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7746341 | pubmed:pagination | 33-7 | lld:pubmed |
| pubmed-article:7746341 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:meshHeading | pubmed-meshheading:7746341-... | lld:pubmed |
| pubmed-article:7746341 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7746341 | pubmed:articleTitle | Current trends in neural transplantation. | lld:pubmed |
| pubmed-article:7746341 | pubmed:affiliation | Department of Neurosurgery, University of Birmingham, Smethwick, UK. | lld:pubmed |
| pubmed-article:7746341 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7746341 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7746341 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
